Intra Artherial Therapies in Treatment of Primary Liver Diseases: an Observational Study
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorIRCCS Azienda Ospedaliero-Universitaria di Bologna
About this trial
The goal of this observational study is to learn what are the best conditions that will give a positive outcome to men and women that receive a intra arterial therapy (IAT) for primary liver cancer.
Intra arterial therapies are radiologic procedures that block liver cancer blood supply.
The researchers will collect the data of participants located in the Radiology department in "IRCCS Azienda Ospedaliera Universitaria" Hospital in Bologna and will study clinic and radiological traits to understand which is the best case scenario for a optimal treatment response.
Eligibility criteria
Qualifiers
Trans-arterial embolization (TAE),
Transarterial chemoembolization (TACE),
Transarterial radioembolization (TARE)
Drug-eluting beads chemoembolization (DEB-TACE)
Disqualifiers
shunt of gastro intestinal arteries that cannot be embolized
metastasis spread outside of the liver
liver failure
Trial design
Treatments tested in this trial
- Not listed
Trial groups
No trial groups listed
Sponsors and collaborators
Source ClinicalTrials.gov